Se encuentra usted aquí

    • You are here:
    • Inicio > Events > Quantitative imaging with Odyssey F

Quantitative imaging with Odyssey F

Quantitative imaging with Odyssey FQuantitative imaging with Odyssey F

09/09/2026

Quantitative imaging with Odyssey F

Aula 4th floor

Learn how to use our new Odyssey F for quantitative imaging.

The Odyssey® F Imaging System is a digital fluorescence imaging platform designed for quantitative Western blot, gel, plate and slide imaging. It uses visible and near-infrared fluorescence detection in 10 different channels to provide high sensitivity, broad dynamic range, and quantitative, unsaturated imaging, enabling multiplexed protein detection and reliable densitometric analysis.

Odyssey F provides dozens of applications:

Gel
  • EMSA/Gel shift assay
  • Glycoprotein staining
  • In-gel western
  • Nucleic acid gel imaging
  • Fluorescent gel staining
Multi-well
  • In-cell western assay
  • On-cell western assay
  • RNAi analysis
  • Fluorescent proteins
  • Cell health assays
Membrane
  • Near-infrared fluorescence WB
  • Visible Fluorescence WB
  • Protein assays
Slides
  • Tissue section imaging
  • Protein arrays
  • Fluorescent proteins

More information about Odyssey F: HERE

Please register below to attend the theoretical training. On the session, you will be asked if you would like to attend the practical session with already prepared samples or you can bring your own samples.

Target audience: CRG staff
Date: 9th September 2026
Schedule:

  • 10:00 - 11:00 Instrument installation (Room 662, 6th floor Hospital Side) - Marc Bataller
  • 11:00 - 12:30 Theoretical training (Aula 4th floor) - Open for everyone
  • 12:30 - 13:30 Practical training (Room 662, 6th floor Hospital Side) - Open for everyone

Instructors: Lea Nästle, LICORbio
Location: Aula room (4th floor)
Registration deadline: 8th September 2026 (2pm)
Registration HERE

For any information, please send an email to CRG Training and Academic Office - TAO at training@crg.eu
 


Training financiado por Ayuda:CEX2020-001049-S financiada por MCIN/ AEI / 10.13039/501100011033